TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny 
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand 
LOS ANGELES, April 20, 2017 -- Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against BioAmber Inc. (“BioAmber” or the “Company”) (NYSE:BIOA) concerning possible violations of federal securities laws. Investors who purchased shares (1) pursuant and/or traceable to BioAmber’s secondary public offering on or about January 23, 2017; and/or (2) on the open market from January 23, 2017 through March 16, 2017 inclusive (the “Class Period”), should contact the firm prior to the May 17, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or e-mail him at [email protected].
No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
According to the Complaint, during the Class Period, BioAmber made materially false and/or misleading statements and/or failed to disclose that a large customer of the Company that was expected to purchase $2.8 million of succinic acid in the fourth quarter of 2016 postponed the order to 2017; and as a result, the Company’s statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When this news was revealed to the public, the stock price of BioAmber lowered, which harmed investors.
Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected] http://lundinlawpc.com/
